The Innovative Medicines Initiative (IMI) is Europe’s largest public-private partnership in life science. It is jointly run and funded by the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA). Its aim is to improve the process of developing new drugs and treatments by supporting cooperation in research and development.
Launched in 2008, the initiative is now being renewed under the EU’s framework programme Horizon 2020. IMI2 will run for 10 years with a budget of approximately €3 billion euro.
The IMI2 launch event in Copenhagen is an opportunity for a wide range of stakeholders to learn about the research priorities of IMI2 and the calls to be launched in 2014. The event will also highlight the experiences and learnings of Swedish and Danish IMI project participants from both industry and academia.
The event is organised by VINNOVA & the Danish Agency for Science, Technology and Innovation and hosted by the Medicon Valley Alliance